journal
Journals International Journal of Clini...

International Journal of Clinical Pharmacology and Therapeutics

https://read.qxmd.com/read/39380547/positive-effects-of-magnesium-supplementation-in-metabolic-syndrome
#1
JOURNAL ARTICLE
Sophia Kisters, Klaus Kisters, Tanja Werner, Jürgen Vormann, Faruk Tokmak, Timm Westhoff, Uwe Gröber, Hans-Georg Predel, Hannes Reuter
INTRODUCTION: Recent data show that magnesium supplementation decreases systolic and diastolic blood pressure values depending on the blood pressure levels and improves metabolic parameters in cardiovascular disease. MATERIALS AND METHODS: In this context, we conducted a prospective, randomized, double-blind study on serum and ionized magnesium, systolic and diastolic blood pressure values, interleukin-6, vitamin D, and metabolic profile in 27 patients (13 male/14 female, age: 60...
October 9, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39380546/a-disproportionality-analysis-of-antipsychotic-induced-hyperprolactinemia-based-on-fda-adverse-event-reporting-system
#2
JOURNAL ARTICLE
Min Song, Dong Li, Jing Peng, Na Wang, Mei Zhang, Xiao-Lei Ren
OBJECTIVE: This study aims to compare the risks of different antipsychotics in causing hyperprolactinemia, taking into account the age, gender, and onset time. MATERIALS AND METHODS: We searched the FDA Adverse Event Reporting System (FAERS) from January 1, 2004, to March 31, 2022, for reports of hyperprolactinemia treated with antipsychotics. We evaluated the association between antipsychotics and the risk of hyperprolactinemia using reporting odds ratio (ROR) based on a disproportionality analysis...
October 9, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39370808/skin-adhesion-of-a-newly-developed-bioequivalent-rotigotine-patch-formulation-in-comparison-to-the-originator-product-results-of-a-multi-center-randomized-crossover-trial-in-patients-with-parkinson-s-disease
#3
JOURNAL ARTICLE
Wolfgang H Jost, Maggie Wang, Gabriel Wauer, Annika Dax, Ralph-Steven Wedemeyer, Barbara Schug, André Warnke, Ana Leblanc, Bjoern Schurad
OBJECTIVES: To demonstrate adequate skin adhesion of a new once-daily rotigotine transdermal patch (ROT-TDS) compared to the originator product (reference) in patients with Parkinson's disease (PD). MATERIALS AND METHODS: Pharmacokinetic bioequivalence (PK BE) was assessed with the 4 mg/24h patches in healthy adults in a single-/multiple-dose, crossover trial. The trial investigating skin adhesion in PD patients (stable dose ≥ 8 mg/day rotigotine) was performed with the 8 mg/24h patches as a multiple-dose, crossover trial (4 alternating once-daily patch applications)...
October 7, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39315482/identification-of-factors-associated-with-vancomycin-induced-acute-kidney-injury-a-retrospective-analysis-using-the-common-data-model
#4
JOURNAL ARTICLE
Sang-In Park, Jung-Kyeom Kim, Uijeong Yu, Ji In Park
OBJECTIVE: Previous findings on predictors of vancomycin-induced acute kidney injury (AKI) are inconsistent. We aimed to identify the predictors of vancomycin-induced AKI using the Observational Medical Outcome Partnership Common Data Model. MATERIALS AND METHODS: We analyzed data from patients treated with vancomycin between January 1, 2012, and May 31, 2022, who were positive for Staphylococcus aureus and had undergone oxacillin susceptibility tests. After excluding patients without data for vancomycin or baseline serum creatinine levels, 116 patients were included in the final dataset...
September 24, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39315481/retrospective-evaluation-of-medical-information-for-predicting-tazobactam-piperacillin-induced-liver-injury
#5
JOURNAL ARTICLE
Takahiro Amemiya, Hiroshi Suzuki
OBJECTIVE: Tazobactam/piperacillin is a first-line treatment option for hospital-acquired pneumonia; however, drug-induced liver injury (DILI) is relatively frequently observed with tazobactam/piperacillin in clinical practice. This study aimed to verify the usefulness of available patient data for predicting DILI prior to tazobactam/piperacillin administration. MATERIALS AND METHODS: Tazobactam/piperacillin-treated patients were retrospectively selected and divided into patients with and without DILI...
September 24, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39292013/comparison-of-uric-acid-elevation-between-aspirin-ticagrelor-and-aspirin-clopidogrel-during-dual-antiplatelet-therapy
#6
JOURNAL ARTICLE
Sojin Park, Sangah Chi, Jeong Hoon Yang, Myungsook Min, Ju-Young Shin
OBJECTIVE: This study investigated whether serum uric acid levels are more elevated in the aspirin-ticagrelor group than in the aspirin-clopidogrel group. Materials and Materials and methods: We conducted a retrospective cohort study with patients between 2013 and 2020. Baseline and maximum serum uric acid levels within a 6-month follow-up period were analyzed to determine the increase in both groups. RESULTS: A total of 41,877 patients were enrolled. A statistically significant elevation of serum uric acid levels was found in the aspirin-ticagrelor group compared to the aspirin-clopidogrel group (odds ratio (OR; 95% confidence interval (CI)) = 1...
September 18, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39239685/a-case-of-a-geriatric-patient-with-thrombocytopenia-after-partial-recovery-from-covid-19
#7
JOURNAL ARTICLE
Yukako Hayashi, Kenji Momo, Mutsumi Ando, Hiroaki Koya, Tsutomu Nagai, Kazuki Shinmura, Issei Tokimatsu, Yasushi Akutsu, Masahiro Kurosawa
The global emergence of -COVID-19 has prompted rapid therapeutic and vaccine advancements; however, clinical evidence remains limited. With around a 50% fatality rate for COVID-19 patients with acute respiratory distress syndrome (ARDS), early intervention is crucial. This report details a severe case of post-COVID-19 thrombocytopenia in a 79-year-old man and emphasizes its critical nature. Despite negative initial COVID-19 test results, subsequent positive results led to treatment initiation, and severe thrombocytopenia persisted resulting in bleeding complications and death...
September 6, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39157918/dosing-strategy-of-tacrolimus-when-co-administered-with-wuzhi-tablet-in-renal-transplant-recipients
#8
JOURNAL ARTICLE
Rui Dai, Yiting Cai, Jun Li, Xiaoman Liu, Qian Fu, Min Huang, Changxi Wang, Pan Chen
OBJECTIVE: Tacrolimus (TAC) is a first-line immunosuppressant to prevent allograft rejection. Wuzhi tablet is widely used as a TAC-sparing agent in China that could significantly elevate TAC exposure. However, insufficient data support the dose recommendation of TAC when co-administered with Wuzhi . MATERIALS AND METHODS: A total of 305 adult renal transplant patients with 2,541 TAC trough concentrations (C0 ) were enrolled for population pharmacokinetic (PPK) modeling...
August 19, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39157917/bioequivalence-study-of-two-formulations-of-afatinib-dimaleate-tablets-in-healthy-subjects-under-fasting-conditions-a-randomized-open-label-single-dose-crossover-trial
#9
JOURNAL ARTICLE
Yanping Liu, Lang Lü, Man Xu, Juanmin Tao, Yuping Ning, Yan Shi, Yanfen Dong, Qingqing Cao, Jun Ma, Yan Qiu
OBJECTIVE: To evaluate the bioequivalence of two different afatinib dimaleate formulations in healthy Chinese subjects under fasting conditions and to assess their pharmacokinetic and safety profiles. MATERIALS AND METHODS: This randomized, open-label, 2-period, crossover, bioequivalence study included 32 healthy Chinese subjects. The subjects were assigned to receive a single 40-mg dose of generic or brand-named afatinib dimaleate tablet. Blood samples were collected pre-dose and up to 120 hours after dosing...
August 19, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39120081/pulmonary-fibrosis-insights-and-therapy-targets-from-disease-models-and-administration-of-the-lipophilic-diterpene-sodium-tanshinone-iia-sulfonate-review-and-meta-analysis
#10
JOURNAL ARTICLE
Li-Ying Peng, Jun-Jun Shi, Yue Liang, Yang Li, Yan Tang, Tuo Kai, Andong Yang, Zi-Yue Xiong
Pulmonary fibrosis (PF) is a chronic and progressive pulmonary interstitial disease of unknown etiology and is also a sequela in severe patients with the Coronavirus Disease 2019 (COVID-19). Seven databases were systematically searched to evaluate the preclinical evidence of Tanshinone IIA (Tan IIA) on PF. The quality of the included studies was assessed using a 10-item risk of bias tool, and data were analyzed using RevMan 5.3 software. 22 experiments from 12 studies on a total of 248 animals were included...
August 9, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39120080/early-acute-kidney-injury-after-tacrolimus-administration-in-heart-transplant-recipients-receiving-basiliximab-induction-therapy
#11
JOURNAL ARTICLE
Megumi Ikura, Tsutomu Nakamura, Kyoichi Wada, Rikako Nagata, Tomoko Ueno, Kazuyoshi Kawabata, Fumiki Yoshihara, Takuya Watanabe, Yasumasa Tsukamoto
OBJECTIVE: In this study, we aimed to analyze the association among the timing of tacrolimus initiation, time required to reach the target blood concentration, and early acute kidney injury (AKI) after tacrolimus administration in heart transplant recipients who received basiliximab induction therapy. MATERIALS AND METHODS: 88 patients treated with tacrolimus-based immunosuppressive therapy were retrospectively reviewed. Induction therapy was administered to 52 patients...
August 9, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39120079/evaluation-of-metronidazole-oral-monotherapy-in-anaerobic-oral-infections
#12
JOURNAL ARTICLE
Najla Dar-Odeh, Ala'a Atef, Yara Flaifl, Dilnoza Bobamuratova, Basem Akily, Rayan Meer, Osama Abu-Hammad
OBJECTIVES: To evaluate the indications and dosing regimens for oral metronidazole monotherapy (OMM) for the management of oral anaerobic infections (OAIs) other than periodontitis. MATERIALS AND METHODS: The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in literature of PubMed/Medline, Scopus, and Cochrane databases. Data were retrieved from reports published in English in the period January 1, 1980 - August 30, 2023...
August 9, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39099387/post-marketing-safety-concerns-with-montelukast-a-pharmacovigilance-study-based-on-the-fda-adverse-event-reporting-system
#13
JOURNAL ARTICLE
Zhimin Ou, Ying Han, Wei Zhuang, Yunshan Xiao, Shuying Cai, Xueqin Zhang
The United States Food and Drug Administration (FDA) has been warning about the psychiatric disorders associated with montelukast (MTK) for years. To study the characteristics of the presence of MTK-associated adverse events (AEs), we obtained data from the FDA Adverse Event Reporting System database and used a case (MTK) vs. non-case (all other drugs) analysis to investigate the safety signals in a disproportionality study. 27,507 reported AEs from January 2004 to December 2022 were analyzed. Disproportionality analysis shows that psychiatric, respiratory, thoracic, and mediastinal disorders as well as social circumstances are the most commonly reported AEs...
August 5, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39078055/pharmacokinetic-bioequivalence-and-safety-assessments-of-two-brands-of-30-mg-nifedipine-controlled-release-formulations-in-chinese-healthy-subjects
#14
JOURNAL ARTICLE
Huan Lu, Fei Zhou, Cuijie Rui, Hen You, Wenhao Zhang, Yaxin Zhang, Juefang Ding, Shunbo Zhao, Qiang Wu
OBJECTIVE: This study aimed to analyze the pharmacokinetic (PK) characteristics, safety, and bioequivalence (BE) of a test (T) preparation of a nifedipine controlled-release tablet and the reference (R) drug (Adalat GTIS) in Chinese study participants in the context of fasting and postprandial states. MATERIALS AND METHODS: An open-label, single-center, randomized, single-dose, two-period study was designed including two separate arms, one with administration under fasting conditions and one with administration under postprandial conditions (high-fat, high-calorie breakfast)...
July 30, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39078054/adequate-ivig-dosing-is-associated-with-an-improved-long-term-outcome-in-secondary-immunodeficiency-a%C3%A2-prospective-non-interventional-study
#15
JOURNAL ARTICLE
Artur Bauhofer, Ümniye Balaban, Sonja Schimo, Monika Mayer, Jörg Schüttrumpf, Stephan Borte
OBJECTIVE: To assess the safety, tolerability, and effectiveness of the intravenous immunoglobulin (IVIG) Intratect 50 g/L in immunoglobulin replacement therapy (IgRT) in a prospective, large-scale non-interventional study (NIS). The analysis focused upon patients with secondary immunodeficiency (SID), the most frequent indication for IgRT in this NIS. MATERIALS AND METHODS: Patients were enrolled at 123 centers in Germany. Each patient received IVIG as prescribed by the physician, guided by the Summary of Product Characteristics...
July 30, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39045734/rational-use-of-short-term-anorectic-drugs-for-one-year-effective-treatment-of-obesity-an-analysis-of-four-studies
#16
JOURNAL ARTICLE
Cynthia Galicia-Quintanar, Héctor Isaac Rocha-González, María Elena Sánchez Mendoza, Jesús Arrieta-Valencia, Juan Rodríguez-Silverio, Geovanna Nallely Quiñonez-Bastidas, Juan Carlos Huerta-Cruz, Lina Marcela Barranco-Garduño, Juan Gerardo Reyes-García
BACKGROUND: Obesity is a complex disease for which pharmacotherapy is often used. Anti-obesity drugs (AODs) are characterized by inducing a variable inter-subject body weight reduction (BWR), the attainment of a plateau after their maximal effect is achieved, and weight regain after drug discontinuation, which complicate individualized treatment of obesity. OBJECTIVE: This exploratory analysis aimed to compare the first-month body weight reduction in kg (1mo-BWRkg) and tolerance development (moT) of four known interventions with low (placebo), intermediate (phentermine or mazindol monotherapy), and high (5 active ingredients fixed-dose combination) efficacy, as predictors of their 6-month body weight reduction efficacy in percent (6mo-BWR%)...
July 24, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39045733/a-decision-tree-model-for-predicting-high-mono-n-desethylamiodarone-concentrations-and-reducing-tissue-toxicity-in-patients-with-low-dose-amiodarone-therapy-a-multicentral-retrospective-cohort-study
#17
JOURNAL ARTICLE
Yuki Asai, Hiroki Arihara, Saki Omote, Ena Tanio, Saena Yamashita, Takashi Higuchi, Ei Hashimoto, Momoko Yamada, Hinako Tsuji, Yoshihiro Kondo, Makoto Hayashi, Takumi Tashiro, Yuji Hayakawa, Yoshiaki Yamamoto, Takuya Iwamoto
OBJECTIVE: High plasma levels of mono- N -desethylamiodarone (MDEA), an active amiodarone metabolite, may be associated with tissue toxicity in heart failure (patients with heart rhythm disturbances); therefore, a tool that can identify patients for whom therapeutic drug monitoring (TDM) of MDEA is required. This multicenter study aimed to develop a decision tree (DT) model that can identify patients with heart rhythm disturbances at high MDEA concentrations. MATERIALS AND METHODS: A multicenter retrospective cohort study was conducted, including 157 adult patients with heart failure who received oral amiodarone treatment...
July 24, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39045732/chronic-myeloid-leukemia-in-an-ulcerative-colitis-patient-receiving-azathioprine-a-case-report
#18
JOURNAL ARTICLE
Asma Mensi, Nouha Trad, Raoudha Mansouri, Wiem Ayed, Emna BelHadj Mabrouk, Yosra Said, Radhouane Debbeche
Ulcerative colitis (UC) is a chronic inflammatory bowel disease usually treated by azathioprine. It is a well-established risk factor for colorectal cancers and extraintestinal malignancies. Nevertheless, the risk of myeloid leukemia in patients with UC is less known. We report a case of a 51-year-old patient, with a history of extensive ulcerative colitis, who was treated with azathioprine at a dose of 2.5 mg/kg/day. Seven years later, he presented an increased count of white blood cells at 25,400/μL and of platelets at 1,382,000/μL...
July 24, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39037110/a-case-study-of-impaired-consciousness-caused-by-alcohol-consumption-in-a%C3%A2-pediatric-patient-taking-high-dose-cefixime
#19
JOURNAL ARTICLE
Li Zheng, Gen Li, Liaoyun Zhang
A variety of drugs have been known to induce disulfiram-like reactions in individuals exposed to ethanol, including certain cephalosporin antibiotics with methylthiotetrazole (MTT) substituents or methylthiodioxotriazine (MTDT) rings. Among cephalosporins, cefixime is known to cause fewer disulfiram-like reactions. This case report, the first involving a pediatric patient, presents the scenario of a 14-year-old female who exhibited drowsiness, loss of consciousness, and cold extremities within an hour after ingesting 9 cefixime capsules...
July 22, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/39037109/population-pharmacokinetic-study-and-application-of-ticagrelor-and-ar-c124910xx-after-percutaneous-coronary-intervention-in-chinese-patients-with-acute-coronary-syndrome
#20
JOURNAL ARTICLE
Meng Liu, Jun Qin, XiaoQian Chu, NaiDong Chen, Qiong Jie, ShaoJun Zheng
OBJECTIVES: This study aimed to understand the pharmacokinetics of ticagrelor in Chinese patients with acute coronary syndrome (ACS), identify influencing factors, and inform ticagrelor treatment optimization. MATERIALS AND METHODS: Data from 195 ACS patients, including 491 plasma ticagrelor concentration timepoints and clinical information, were analyzed using NONMEN for pharmacokinetic (PK) parameter factors. The model underwent internal validation with bootstrap methodology...
July 22, 2024: International Journal of Clinical Pharmacology and Therapeutics
journal
journal
31654
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.